Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03941275 · ClinicalTrials.gov registry record
SelectSecure 3830 Lead Imaging
A clinical trial of Heart Diseases, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- 51
- Enrollment target
- 4
- Study locations
NCT03941275: Completed study of Heart Diseases, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
NCT03941275 is a study of Heart Diseases that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 51 participants, below the 5,532-participant average among 85 other Heart Diseases trials with a reported enrollment target (99% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03941275, a study of Heart Diseases, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- 51 participants
- Enrollment target
- 4
- Study locations
Study Summary
This study is designed to collect high-quality shoulder and intracardiac bi-plane fluoroscopic images during two standard arm motions on patients implanted with a market released SelectSecure 3830 lead for the purposes of developing a fracture reliability model.
Primary Outcome
Fluoroscopic cine images will be collected in conjunction with a specialized calibration object. When imaging data is processed and analyzed it will characterize the time-varying lead shape changes.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Bi-plane fluoroscopy
Study Locations (4)
Alabama
- Heart Center Research - Huntsville
Iowa
- Iowa Heart Center - West Des Moines
Maryland
- Associates in Cardiology PA - Silver Spring
New Jersey
- Lourdes Cardiology Services - Voorhees Township
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2019-05-24 |
| Est. Completion | 2021-11-15 |
What the finished NCT03941275 record still lists
NCT03941275 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 51 participants, a relatively small participant target, below the 5,532-participant average among 85 other Heart Diseases trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Heart Diseases appearing as the primary indexed condition, and to 1 intervention - of which Bi-plane fluoroscopy is the first listed.
NCT03941275 reports a single indexed study location in Alabama, Iowa, Maryland.
Frequently Asked Questions
What is clinical trial NCT03941275 about?
NCT03941275 is a clinical study titled "SelectSecure 3830 Lead Imaging". This study is designed to collect high-quality shoulder and intracardiac bi-plane fluoroscopic images during two standard arm motions on patients implanted with a market released SelectSecure 3830 lead for the purposes of developing a fracture reliability model.
What is the current status of trial NCT03941275?
This trial is currently completed. The enrollment target is 51 participants. The study started on 2019-05-24. Estimated completion is 2021-11-15.
What conditions does trial NCT03941275 study?
This clinical trial studies the following conditions: Heart Diseases.
What interventions are being tested in trial NCT03941275?
The interventions under investigation include: Bi-plane fluoroscopy (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03941275?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03941275 being conducted?
This trial has 4 study locations across Alabama, Iowa, Maryland, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03941275's enrollment target sits among peer trials
51 76th of 85 higher than 10 of 85 other Heart Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Angiography and Electrogram Guided Bachmann Bundle Pacing
RECRUITING · NA
-
Understanding Decentralized Trial Engagement and Clinical Impediments Through Digital Efforts (UDECIDE) Among Unrepresented Groups With Poor Cardiovascular and Cardiometabolic Health
RECRUITING · NA
-
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
RECRUITING · NA
-
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR
RECRUITING · NA
-
Lumason® Infusion vs. Bolus Administrations
RECRUITING · Phase 3
-
American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study)
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI